P4Q becomes strong in health. The Basque manufacturer of advanced electronics has entered the health sector with the launch of its subsidiary Qassay, which has developed a device that detects diseases associated with There are plans to enter one million euros in 2023 and two million euros in 2024According to Javier Lezama, director of business development for the group.
Qasay’s product medical tests and studies measures the prevalence of diseases in organisms These include diseases such as cancer, diabetes, sexually transmitted diseases or heart defects.
Through the digitization of the reading of diseases, Casey arranges for the data to be sent to the relevant health authorities and other companies in the sector, to save costs for the system and increase access to diagnostics for patients who do not have to visit a health center to find out if they are suffering from a disease.
Kase has entered into an agreement with the Norwegian public system to manage 15,000 devices
Qassay has started rolling out in Norway Through an agreement with various public hospitals in the Nordic country, which has ordered 15,000 devices for C-reactive protein testing.
This year, the group plans to start marketing in Europe and Sell ​​20,000 units of your equipment, which will increase to 50,000 units in 2024, After landing in Norway, P4Q would like to grow in Spain with an eye on the United States, its biggest potential market, but the group is also in talks with customers in France or the United Arab Emirates.
“The US healthcare system is much more cost-effective for us, as we can maximize savings and reduce the cost of the system; In Europe, on the other hand, it is different”, highlights Lezama, who explains that the long-term objective is to start produces butcher equipment in the United States and China, where the group’s parent company already has production plants,
The group aspires to produce in the United States and China, where its parent company already has production plants.
Now the company will seek More agreements with companies in the region, “Case is capable of reading any type of rapid test, from flu to vitamins to cardiovascular problems, so its market is very broad,” the executive explains.
P4Q, Qassay’s parent company, is dedicated to the manufacture of electronic components for the energy, railway and automotive sectors. The group has 280 employees and three production plants: one in the Basque Country, another in China and another in the United States. The company has set a target of entering 90 million euros in 2023, which is twice as much as last year.
